Literature DB >> 16412522

Platelet 5-HT2A receptor binding and tryptophan availability in depression are not associated with recent history of suicide attempts but with personality traits characteristic for suicidal behavior.

Erik Lauterbach1, Jürgen Brunner, Barbara Hawellek, Ute Lewitzka, Marcus Ising, Brigitta Bondy, Marie Luise Rao, Christine Frahnert, Dan Rujescu, Bruno Müller-Oerlinghausen, Jürgen Schley, Isabella Heuser, Wolfgang Maier, Fritz Hohagen, Werner Felber, Thomas Bronisch.   

Abstract

BACKGROUND: Abnormalities in the serotonergic (5-HT) system have been implicated in the pathogenesis of suicidal behavior. Studies on peripheral serotonergic parameters as a measure for central serotonergic function in suicidal patients appear to be promising, yet failed to show a clear association with suicidality. The objective of this study was to elucidate the role of serotonergic blood parameters in depressed suicidal patients and to examine their usefulness as a potential biological marker for suicidality. A number of personality traits were assessed in order to provide a basis for a psychobiological model of suicidal behavior.
METHODS: Depressed patients with a recent suicide attempt (SA; n = 59) were compared to those without history of suicide attempts (NSA; n = 28). 5-HT2A receptor binding in platelets and tryptophan/amino acid ratio in plasma were measured. Acute psychopathology and personality traits as well as characteristics of suicide attempts were assessed.
RESULTS: There was no significant difference between SA and NSA in terms of peripheral serotonergic parameters as well as personality traits. However, the whole sample showed associations between certain personality traits and serotonergic platelet parameters. Furthermore, we observed a relation between suicidal ideation, lethality of suicide attempts and peripheral serotonergic markers. LIMITATIONS: The number of cases with data on peripheral markers is relatively low. The potential influence of antidepressant medication previous to study inclusion has to be taken into account. The study focussed on depressed patients only.
CONCLUSIONS: Low serotonergic function is involved in the pathogenesis of suicidality, whereas the use of platelet 5-HT2A receptor activity and tryptophan availability as biological markers for suicidality in depressed patients could not be proven an appropriate tool. Alterations in the serotonergic system are associated with trait aggression and other character dimensions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412522     DOI: 10.1016/j.jad.2005.11.016

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  7 in total

1.  Biologic effects of mindfulness meditation: growing insights into neurobiologic aspects of the prevention of depression.

Authors:  Simon N Young
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

2.  Peripheral serotonergic markers in acutely suicidal patients. 1. Comparison of serotonergic platelet measures between suicidal individuals, nonsuicidal patients with major depression and healthy subjects.

Authors:  J Roggenbach; B Müller-Oerlinghausen; L Franke; R Uebelhack; S Blank; B Ahrens
Journal:  J Neural Transm (Vienna)       Date:  2006-09-21       Impact factor: 3.575

3.  Inflammation and nitro-oxidative stress in current suicidal attempts and current suicidal ideation: a systematic review and meta-analysis.

Authors:  Asara Vasupanrajit; Ketsupar Jirakran; Chavit Tunvirachaisakul; Marco Solmi; Michael Maes
Journal:  Mol Psychiatry       Date:  2022-01-08       Impact factor: 13.437

4.  Norepinephrine-mediated regulation of 5HT1 receptor functioning in human platelets.

Authors:  M L Trincavelli; S Cuboni; M Montali; S Santaguida; A Lucacchini; C Martini
Journal:  Neurochem Res       Date:  2008-02-13       Impact factor: 3.996

Review 5.  The role of the serotonergic system at the interface of aggression and suicide.

Authors:  M Bortolato; N Pivac; D Muck Seler; M Nikolac Perkovic; M Pessia; G Di Giovanni
Journal:  Neuroscience       Date:  2013-01-16       Impact factor: 3.590

6.  Platelets in psychiatric disorders.

Authors:  Daniela Ehrlich; Christian Humpel
Journal:  World J Psychiatry       Date:  2012-12-22

7.  A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder: The Role of Platelet IRAS/Nischarin (I1-Imidazoline Receptor).

Authors:  Benjamin Keller; Joan-Ignasi Mestre-Pinto; María Álvaro-Bartolomé; Diana Martinez-Sanvisens; Magí Farre; M Julia García-Fuster; Jesús A García-Sevilla; Marta Torrens
Journal:  Front Psychiatry       Date:  2017-12-01       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.